Literature DB >> 18422499

Diagnosis of hyperthyroidism in cats with mild chronic kidney disease.

J Wakeling1, K Moore, J Elliott, H Syme.   

Abstract

OBJECTIVES: In cats with concurrent hyperthyroidism and non-thyroidal illnesses such as chronic kidney disease, total thyroxine concentrations are often within the laboratory reference range (19 to 55 nmol/l). The objective of the study was to determine total thyroxine, free thyroxine and/or thyroid-stimulating hormone concentrations in cats with mild chronic kidney disease.
METHODS: Total thyroxine, free thyroxine and thyroid-stimulating hormone were measured in three groups. The hyperthyroidism-chronic kidney disease group (n=16) had chronic kidney disease and clinical signs compatible with hyperthyroidism but a plasma total thyroxine concentration within the reference range. These cats were subsequently confirmed to be hyperthyroid at a later date. The chronic kidney disease-only group (n=20) had chronic kidney disease but no signs of hyperthyroidism. The normal group (n=20) comprised clinically healthy senior (>8 years) cats.
RESULTS: In 4 of 20 euthyroid chronic kidney disease cats, free thyroxine concentrations were borderline or high (> or =40 pmol/l). In the hyperthyroidism-chronic kidney disease group, free thyroxine was high in 15 of 16 cats, while thyroid-stimulating hormone was low in 16 of 16 cats. Most hyperthyroidism-chronic kidney disease cats (14 of 16) had total thyroxine greater than 30 nmol/l, whereas all the chronic kidney disease-only cats had total thyroxine less than 30 nmol/l. CLINICAL SIGNIFICANCE: The combined measurement of free thyroxine with total thyroxine or thyroid-stimulating hormone may be of merit in the diagnosis of hyperthyroidism in cats with chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422499     DOI: 10.1111/j.1748-5827.2008.00544.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  8 in total

1.  Use of thyroid stimulating hormone (TSH) in cats.

Authors:  Jennifer Wakeling
Journal:  Can Vet J       Date:  2010-01       Impact factor: 1.008

2.  Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.

Authors:  U Sent; R Gössl; J Elliott; H M Syme; T Zimmering
Journal:  J Vet Intern Med       Date:  2015-10-16       Impact factor: 3.333

3.  Evaluation of thyroid-stimulating hormone, total thyroxine, and free thyroxine concentrations in hyperthyroid cats receiving methimazole treatment.

Authors:  C Aldridge; E N Behrend; L G Martin; K Refsal; R J Kemppainen; H P Lee; K Chciuk
Journal:  J Vet Intern Med       Date:  2015-04-01       Impact factor: 3.333

4.  Evaluation of Serum Thyroid-Stimulating Hormone Concentration as a Diagnostic Test for Hyperthyroidism in Cats.

Authors:  M E Peterson; J N Guterl; R Nichols; M Rishniw
Journal:  J Vet Intern Med       Date:  2015-07-20       Impact factor: 3.333

5.  Correlation of thyroid hormone measurements with thyroid stimulating hormone stimulation test results in radioiodine-treated cats.

Authors:  Jennifer Wakeling; Teresa Hall; Timothy L Williams
Journal:  J Vet Intern Med       Date:  2020-10-12       Impact factor: 3.333

Review 6.  Hyperthyroid cats and their kidneys: a literature review.

Authors:  L Yu; L Lacorcia; T Johnstone
Journal:  Aust Vet J       Date:  2022-06-16       Impact factor: 1.343

7.  Effect on renal function of restoration of euthyroidism in hyperthyroid cats with iatrogenic hypothyroidism.

Authors:  T L Williams; J Elliott; H M Syme
Journal:  J Vet Intern Med       Date:  2014-04-28       Impact factor: 3.333

8.  Serum thyroxine and thyrotropin concentrations decrease with severity of nonthyroidal illness in cats and predict 30-day survival outcome.

Authors:  Mark E Peterson; Danielle L Davignon; Nicole Shaw; Eric Dougherty; Mark Rishniw; John F Randolph
Journal:  J Vet Intern Med       Date:  2020-10-01       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.